The European Commission’s Pharmaceutical Sector Inquiry raised significant concerns regarding so-called “reverse payment” patent settlement agreements. In this article, CRA describes the types of information or economic evidence that might facilitate evaluation of the competitive aspects of these settlements. To read the article, click here:
Digital platform regulation: Making markets work for people
Digital Platform Regulation: Making Markets Work for People by Fiona Scott Morton explores how improved rules, and regulatory frameworks can promote competition